Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. 2002

Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
First Department of Pathology, Kanazawa Medical University, Ishikawa, Japan.

The modifying effect of dietary administration of the polyphenolic antioxidant flavonoid silymarin, isolated from milk thistle [Silybum marianum (L.) Gaertneri], on AOM-induced colon carcinogenesis was investigated in male F344 rats. In the short-term study, the effects of silymarin on the development of AOM-induced colonic ACF, being putative precursor lesions for colonic adenocarcinoma, were assayed to predict the modifying effects of dietary silymarin on colon tumorigenesis. Also, the activity of detoxifying enzymes (GST and QR) in liver and colonic mucosa was determined in rats gavaged with silymarin. Subsequently, the possible inhibitory effects of dietary feeding of silymarin on AOM-induced colon carcinogenesis were evaluated using a long-term animal experiment. In the short-term study, dietary administration of silymarin (100, 500 and 1,000 ppm in diet), either during or after carcinogen exposure, for 4 weeks caused significant reduction in the frequency of colonic ACF in a dose-dependent manner. Silymarin given by gavage elevated the activity of detoxifying enzymes in both organs. In the long-term experiment, dietary feeding of silymarin (100 and 500 ppm) during the initiation or postinitiation phase of AOM-induced colon carcinogenesis reduced the incidence and multiplicity of colonic adenocarcinoma. The inhibition by feeding with 500 ppm silymarin was significant (p < 0.05 by initiation feeding and p < 0.01 by postinitiation feeding). Also, silymarin administration in the diet lowered the PCNA labeling index and increased the number of apoptotic cells in adenocarcinoma. beta-Glucuronidase activity, PGE(2) level and polyamine content were decreased in colonic mucosa. These results clearly indicate a chemopreventive ability of dietary silymarin against chemically induced colon tumorigenesis and will provide a scientific basis for progression to clinical trials of the chemoprevention of human colon cancer.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001397 Azoxymethane A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.
D012838 Silymarin A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent. Carsil,Karsil,Legalon,Silimarin

Related Publications

Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
January 1991, Nutrition and cancer,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
December 1988, Cancer research,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
December 1997, The Journal of nutrition,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
January 2002, Asian Pacific journal of cancer prevention : APJCP,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
April 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
July 1986, Cancer research,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
July 1984, Journal of the National Cancer Institute,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
August 1993, Carcinogenesis,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
June 1991, Cancer research,
Hiroyuki Kohno, and Takuji Tanaka, and Kunihiro Kawabata, and Yoshinobu Hirose, and Shigeyuki Sugie, and Hiroyuki Tsuda, and Hideki Mori
September 1990, Cancer research,
Copied contents to your clipboard!